Eniola’s strong computational and AI/ML background (LLM serving, data pipelines, Bayesian modelling) aligns with the technical side of AI governance, but the programme focuses on AI risk policy rather than neuropharmacology or drug‑resistance research. The remote, global nature and early‑career focus make it a plausible secondary opportunity, though it is not a direct match to the applicant’s primary scientific agenda.